Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and malondialdehyde

olmesartan has been researched along with malondialdehyde in 6 studies

Compound Research Comparison

Studies
(olmesartan)		Trials
(olmesartan)		Recent Studies (post-2010)
(olmesartan)		Studies
(malondialdehyde)		Trials
(malondialdehyde)		Recent Studies (post-2010) (malondialdehyde)
84118555427,8491,40513,922

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Fujita, E; Higo, S; Hirama, A; Iino, Y; Kaneko, T; Katayama, Y; Mii, A; Mishina, M; Ueda, K; Utsumi, K; Watanabe, Y; Yasuda, F1
Chuang, YC; Fang, KM; Su, YK; Wu, MS1
Araújo, AA; de Castro Brito, GA; do Socorro Costa Feitosa Alves, M; Fernandes de Araújo, R; Lopes de Souza, G; Lourenço, Y; Sabóia Aragão, K; Souza, TO; Xavier de Medeiros, CA1
Dimitriadis, F; Kinoshita, Y; Martin, DT; Ohmasa, F; Oikawa, R; Oiwa, H; Saito, M; Satoh, I; Shimizu, S; Tomita, S; Tsounapi, P1
de Araújo Júnior, RF; de Araújo, AA; de Medeiros, CA; de Menezes, MS; Guerra, GC1
Abd El Fattah, MA; Ahmed, KA; Aziz, MM; Sayed, HM1

Other Studies

6 other study(ies) available for olmesartan and malondialdehyde

ArticleYear
Effects of olmesartan and imidapril on the plasma adiponectin, P-selectin, and MDA-LDL levels of diabetic nephropathy patients.
    Clinica chimica acta; international journal of clinical chemistry, 2012, Jan-18, Volume: 413, Issue:1-2

    Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Imidazoles; Imidazolidines; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; P-Selectin; Tetrazoles

2012
Effects of olmesartan on arterial stiffness in rats with chronic renal failure.
    Cardiovascular diabetology, 2012, Jun-13, Volume: 11

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Aorta; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Glycation End Products, Advanced; Hemodynamics; Hypertrophy, Left Ventricular; Imidazoles; Kidney Failure, Chronic; Male; Malondialdehyde; Nephrectomy; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Vascular Stiffness

2012
Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:10

    Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Gingiva; Imidazoles; Interleukin-1beta; Male; Malondialdehyde; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Osteoprotegerin; Periodontitis; Peroxidase; RANK Ligand; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; Tetrazoles; Tumor Necrosis Factor-alpha

2013
Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
    Neurourology and urodynamics, 2014, Volume: 33, Issue:3

    Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Male; Malondialdehyde; Nerve Growth Factor; NF-E2-Related Factor 2; Nifedipine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar; Regional Blood Flow; Tetrazoles; Urinary Bladder; Urinary Bladder Diseases; Urodynamics

2014
Olmesartan Prevented Intra-articular Inflammation Induced by Zymosan in Rats.
    Biological & pharmaceutical bulletin, 2016, Volume: 39, Issue:11

    Topics: Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Arthritis, Experimental; Aspartate Aminotransferases; Creatinine; Cyclooxygenase 2; Glutathione; Glutathione Peroxidase; Imidazoles; Interleukin-17; Leukocyte Count; Male; Malondialdehyde; Peroxidase; Rats, Wistar; Superoxide Dismutase; Synovial Membrane; Tetrazoles; Tumor Necrosis Factor-alpha; Urea; Zymosan

2016
Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
    Canadian journal of physiology and pharmacology, 2020, Volume: 98, Issue:4

    Topics: Animals; Antioxidants; Apoptosis; Cardiotoxicity; Carnitine; Creatine Kinase, MB Form; Doxorubicin; Heart; Imidazoles; Inflammation; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardium; Oxidative Stress; Protective Agents; Rats; Tetrazoles; Troponin I; Tumor Necrosis Factor-alpha

2020